company

INCYTE BIOSCIENCES NORWAY AS

0164 OSLO

Return on Equity
29,3 %
Current Ratio
1,18
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue4 249 000
Net Income143 000
Total Assets2 924 000
Total Equity488 000
Income (NOK)2022
Revenue4 249 000
Expenditure4 048 000
Operating Profit201 000
Financial Income0
Financial Costs17 000
Financial Balance−17 000
Earnings Before Tax184 000
Tax40 000
Net Income143 000
Balance (NOK)2022
Total Fixed Assets58 000
Total Current Assets2 866 000
Total Assets2 924 000
Total Retained Equity458 000
Total Equity488 000
Total Long-Term Debt0
Total Current Debt2 435 000
Total Equity and Debt2 924 000
Cash flow (NOK)2022
Sales Income4 249 000
Other Income0
Revenue4 249 000
Cost of Goods Sold0
Salary Costs3 113 000
Depreciation0
Impairment0
Expenditure4 048 000
Operating Profit201 000
Financial Income0
Financial Costs17 000
Financial Balance−17 000
Dividends0
Net Income143 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets58 000
Total Fixed Assets58 000
Stock0
Total Investments0
Cash, Bank551 000
Total Current Assets2 866 000
Total Assets2 924 000
Total Equity488 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors1 651 000
Unpaid Taxes144 000
Dividends0
Other Current Debt600 000
Total Current Debt2 435 000
Total Equity and Debt2 924 000
Financial indicators2022
Return on Equity29,3 %
Debt-to-Equity Ratio0
Operating Profit Margin4,73 %
Current Ratio1,18
Quick Ratio1,18
Equity Ratio0,17
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English